The
dangers of bextra were officially spelled out on www.bextra.com
during the first week of April, when this Pfizer website announced
that the U.S. Food and Drug Administration had demanded the
suspension of Bextra sales due to the dangers of bextra and
its cardiovascular and gastrointestinal risks. Bextra, and other
prescription non-steroidal anti-inflammatory arthritis medicines
are attributed to an increased risk of hazardous cardiovascular
and circulation problems including strokes and heart attacks.
As well as rare and potentially fatal reactions to the skin,
specifically the life threatening disease of the skin known
as Stevens-Johnson Syndrome. The website gives more information
on the dangers of bextra recall and bextra side effects, you can do a Google
search or type in Bextra on Ask Jeeves and you will find out
what you need to know.
Bextra
was considered to be a commonly used drug in the successful
treatment and pain control of arthritis and its symptoms like
inflammation. Belonging to the class of pharmaceutical drugs
called ‘COX-2 Inhibitors’, the dangers of bextra
came to the forefront following the Vioxx recall in September
of last year, when further research showed that the same, serious
problems associated with Vioxx could be found with Bextra.
Other
world health organizations in North America including Health
Canada, and medical organizations across Europe also called
for Pfizer to halt Bextra sales, so the drug cannot be purchased
from any pharmacy, hospital or medical clinic across North America
and Europe.
An American Health Association further report determined the
dangers of bextra, stating that patients on Bextra suffered twice as
many strokes and heart attacks than people given a placebo drug.
Findings were made based on data culled from twelve unassociated
studies in a clinical setting. Pfizer has apparently tried to
refute the dangers of bextra, using their own statistics from
a clinical trial that found Bextra to be a non-factor in heart
attacks and strokes. But it was discovered that this study monitored
users of the drug for under a year, whereas it is now medically
believed that the increased health risks become apparent after
more than a year of usage, taking patients more than 18 months
to truly discover the dangers of bextra. |
